Skip to main content

Table 2 Treatments and clinical outcomes of patients by group

From: Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients

  HD-CRB n = 34 (100 %) Non-HD-CRB n = 184 (100 %) p
Treatment (within 48 h)    
 Catheter removal 27 (79.4) 155 (84.2) .555
 Vancomycin therapy 28 (82.3) 78 (42.4) <.001
 Appropriate ATB therapya 31 (91.2) 118 (64.1) .002
Outcome    
 Persistent bacteraemia 3d 5 (14.7) 37 (20.1) .463
 Persistent bacteraemia 7d 2 (5.9) 26 (14.1) .533
 Complicated bacteraemia 11 (32.4) 89 (48.4) .095
 Distant secondary focus 5 (15.2) 38 (20.7) .465
 Endocarditis 0 10 (5.4) .368
 Recurrence 3 (8.8) 4 (2.2) .076
 Early mortality (48 h) 0 7 (3.8) .599
 Overall mortality (30d) 4 (11.8) 49 (27.2) .081
  1. aATB therapy: Antibiotic therapy